Publications

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer

Published in Nature Communications, 2020

Liquid biopsies may be confounded by alterations arising from clonal hematopoeisis. This study uses targeted sequencing of matched cfDNA and white blood cells to distinguish cfDNA from other cfDNA alterations and highlights the utility of ctDNA as a predictive biomarker of patient outcome to perioperative cancer therapy and surgical resection in patients with gastric cancer.

Recommended citation: Leal A et al. (2020). "White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer" Nature Communications 11(1). http://rscharpf.github.io/files/leal_naturecomm_2020.pdf